Entia Biosciences, Inc. booked $265.5k in FY2016 revenue, contracting 23% year over year — slower than 74% of Healthcare companies we track, at a -525.8% net margin.
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.